News – Page 693 – Endpoints News

FDA pushes back Ascendis' PDUFA for long-acting hormone therapy; Debiopharm takes home a win in mid-stage test for ...

4 years ago

Terns Pharmaceuticals touts safety data from an ex-Eli Lilly candidate in the hunt for NASH treatment

4 years ago

‘You have to get up on the podium’: Incoming BIO chair Paul Hastings on diversity, drug pricing and working with ...

4 years ago

A snakebit biotech receives second CRL for reformulated pain med, potentially putting the kibosh on its chances

4 years ago

Looking beyond the pandemic, Moderna appoints J&J veteran Paul Burton as new CMO

4 years ago

Top analyst maps a rocky road for Vertex — unless they adopt a $10B M&A campaign to save the pipeline

4 years ago

In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment

4 years ago

Covid-19 roundup: Germany puts J&J on the hotseat for vaccine backorder; Top EMA official suggests forgoing ...

4 years ago

75M vaccine doses wasted: FDA spells out Emergent facility deficiencies at length in new memo

4 years ago

Hal Barron gambles $625M cash on high-wire TIGIT act, throwing GlaxoSmithKline into heated race and completing ...

4 years ago

Long-awaited Novavax PhIII results show 90.3% overall efficacy, with 100% effectiveness against moderate and severe ...

4 years ago

As Covid-19 shifts the world's attention to biotech, Noubar Afeyan's Flagship builds $3.4B fund to fuel new ...

4 years ago

Unpacking the Aduhelm decision, Vertex's half full glass, a $525M J&J breakup, and more

4 years ago

As it expands its footprint, Moderna reaches deal to commercialize Covid-19 vaccine doses in Middle East

4 years ago

FDA authorizes about 10M J&J vaccine doses, trashes 60M more from troubled Emergent plant

4 years ago

Autolus claims a CAR-T win at EHA; Imago touts two PhII trial wins for rare disease drug

4 years ago

The IPO 4-1-1: Four filings, a pricing and a withdrawal headline this week's Nasdaq action as raise approaches $7.5B

4 years ago

Intercept retools C-suite with a pair of newcomers; Charles Ryan moves past Alzheimer's flops with another CEO ...

4 years ago

Months after FDA rejection, Sanofi touts pivotal win for rare disease drug sutimlimab as it preps to refile

4 years ago

An expensive watch, shell companies and fake invoices: How two Israeli traders tapped into a $100M global biotech ...

4 years ago

Fresh off $598M deal with Novo Nordisk, a Japanese stem cell company is on its way to the clinic with a different ...

4 years ago

Covid-19 roundup: 60 million J&J doses from Emergent to be tossed; EMA updates AstraZeneca vaccine warnings

4 years ago

Vertex and CRISPR Therapeutics unveil more positive gene therapy data, but busulfan again casts a shadow over the ...

4 years ago

Senators lambast new Alzheimer’s drug’s price but give Janet Woodcock a free pass on the approval decision

4 years ago

First page Previous page 690 691 692693694 695 696 Next page Last page